Literature DB >> 16708405

Persistent antigenic stimulation alters the transcription program in T cells, resulting in antigen-specific tolerance.

Per O Anderson1, Barbara A Manzo, Anette Sundstedt, Sophie Minaee, Alistair Symonds, Sabah Khalid, Maria E Rodriguez-Cabezas, Kirsty Nicolson, Suling Li, David C Wraith, Ping Wang.   

Abstract

Repetitive antigen stimulation induces peripheral T cell tolerance in vivo. It is not known, however, whether multiple stimulations merely suppress T cell activation or, alternatively, change the transcriptional program to a distinct, tolerant state. In this study, we have discovered that STAT3 and STAT5 were activated in response to antigen stimulation in vivo, in marked contrast to the suppression of AP-1, NF-kappaB and NFAT. In addition, a number of transcription factors were induced in tolerant T cells following antigen challenge in vivo, including T-bet, Irf-1 and Egr-2. The altered transcription program in tolerant cells associates closely with the suppression of cell cycle progression and IL-2 production, as well as with the induction of IL-10. Studies of T-bet and Egr-2 show that the function of T-bet in peptide treatment-induced regulatory T cells is not associated with Th1 differentiation, but correlates with the suppression of IL-2, whereas expression of Egr-2 led to an up-regulation of the cell cycle inhibitors p21(cip1) and p27(kip). Our results demonstrate a balanced transcription program regulated by different transcription factors for T cell activation and/or tolerance during antigen-induced T cell responses. Persistent antigen stimulation can induce T cell tolerance by changing the balance of transcription factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16708405      PMCID: PMC2652694          DOI: 10.1002/eji.200635883

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  47 in total

Review 1.  T cell anergy.

Authors:  Ronald H Schwartz
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

2.  Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo.

Authors:  Anette Sundstedt; Emma J O'Neill; Kirsty S Nicolson; David C Wraith
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

3.  Rb-associated protein 46 (RbAp46) suppresses the tumorigenicity of adenovirus-transformed human embryonic kidney 293 cells.

Authors:  L S Guan; G C Li; C C Chen; L Q Liu; Z Y Wang
Journal:  Int J Cancer       Date:  2001-08-01       Impact factor: 7.396

4.  T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells.

Authors:  A A Lighvani; D M Frucht; D Jankovic; H Yamane; J Aliberti; B D Hissong; B V Nguyen; M Gadina; A Sher; W E Paul; J J O'Shea
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

5.  Characterization of the gene encoding mouse retinoblastoma binding protein-7, a component of chromatin-remodeling complexes.

Authors:  Jing Yang; Susan Kiefer; Michael Rauchman
Journal:  Genomics       Date:  2002-10       Impact factor: 5.736

6.  The N-terminal 24 amino acids of the p55 gamma regulatory subunit of phosphoinositide 3-kinase binds Rb and induces cell cycle arrest.

Authors:  Xianmin Xia; Aiwu Cheng; Damilola Akinmade; Anne W Hamburger
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

7.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

8.  An essential role for Scurfin in CD4+CD25+ T regulatory cells.

Authors:  Roli Khattri; Tom Cox; Sue-Ann Yasayko; Fred Ramsdell
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

9.  Transcriptional mechanisms underlying lymphocyte tolerance.

Authors:  Fernando Macián; Francisco García-Cózar; Sin-Hyeog Im; Heidi F Horton; Michael C Byrne; Anjana Rao
Journal:  Cell       Date:  2002-06-14       Impact factor: 41.582

10.  In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.

Authors:  Franck J Barrat; Daniel J Cua; André Boonstra; David F Richards; Chad Crain; Huub F Savelkoul; René de Waal-Malefyt; Robert L Coffman; Catherine M Hawrylowicz; Anne O'Garra
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

View more
  26 in total

Review 1.  IL-10 production by CD4+ effector T cells: a mechanism for self-regulation.

Authors:  D Jankovic; D G Kugler; A Sher
Journal:  Mucosal Immunol       Date:  2010-03-03       Impact factor: 7.313

2.  Evaluating a Multiscale Mechanistic Model of the Immune System to Predict Human Immunogenicity for a Biotherapeutic in Phase 1.

Authors:  Lora Hamuro; Giridhar S Tirucherai; Sean M Crawford; Akbar Nayeem; Renuka C Pillutla; Binodh S DeSilva; Tarek A Leil; Craig J Thalhauser
Journal:  AAPS J       Date:  2019-07-24       Impact factor: 4.009

Review 3.  Danger signals activating innate immunity in graft-versus-host disease.

Authors:  Robert Zeiser; Olaf Penack; Ernst Holler; Marco Idzko
Journal:  J Mol Med (Berl)       Date:  2011-05-15       Impact factor: 4.599

4.  Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production.

Authors:  Kaoru Morita; Tomohisa Okamura; Mariko Inoue; Toshihiko Komai; Shuzo Teruya; Yukiko Iwasaki; Shuji Sumitomo; Hirofumi Shoda; Kazuhiko Yamamoto; Keishi Fujio
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-30       Impact factor: 11.205

5.  Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3.

Authors:  Sam Collins; Michael A Lutz; Paul E Zarek; Robert A Anders; Gilbert J Kersh; Jonathan D Powell
Journal:  Eur J Immunol       Date:  2008-02       Impact factor: 5.532

Review 6.  Therapeutic peptide vaccines for treatment of autoimmune diseases.

Authors:  David C Wraith
Journal:  Immunol Lett       Date:  2008-12-25       Impact factor: 3.685

7.  The transcription factors Egr2 and Egr3 are essential for the control of inflammation and antigen-induced proliferation of B and T cells.

Authors:  Suling Li; Tizong Miao; Meera Sebastian; Punamdip Bhullar; Emma Ghaffari; Mengya Liu; Alistair L J Symonds; Ping Wang
Journal:  Immunity       Date:  2012-09-27       Impact factor: 31.745

8.  The helminth product, ES-62, protects against airway inflammation by resetting the Th cell phenotype.

Authors:  Justyna Rzepecka; Ivonne Siebeke; Jennifer C Coltherd; Dorothy E Kean; Christina N Steiger; Lamyaa Al-Riyami; Charles McSharry; Margaret M Harnett; William Harnett
Journal:  Int J Parasitol       Date:  2013-01-03       Impact factor: 3.981

9.  Apoptosis of CD4+ CD25(high) T cells in type 1 diabetes may be partially mediated by IL-2 deprivation.

Authors:  Parthav Jailwala; Jill Waukau; Sanja Glisic; Srikanta Jana; Sarah Ehlenbach; Martin Hessner; Ramin Alemzadeh; Shigemi Matsuyama; Purushottam Laud; Xujing Wang; Soumitra Ghosh
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240

10.  Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells.

Authors:  Leona Gabrysová; Kirsty S Nicolson; Heather B Streeter; Johan Verhagen; Catherine A Sabatos-Peyton; David J Morgan; David C Wraith
Journal:  J Exp Med       Date:  2009-07-27       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.